Document Detail


Implementation of a management guideline aimed at minimizing the severity of primary graft dysfunction after lung transplant.
MedLine Citation:
PMID:  19909995     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Primary graft dysfunction, a severe form of lung injury that occurs in the first 72 hours after lung transplant, is associated with morbidity and mortality. We sought to assess the impact of an evidence-based guideline as a protocol for respiratory and hemodynamic management. METHODS: Preoperative and postoperative data for patients treated per the guideline (n = 56) were compared with those of a historical control group (n = 53). Patient data such as ratio of arterial Po(2) to inspired oxygen fraction, central venous pressure, cumulative fluid balance, vasopressor dose, and serum urea and creatinine were measured and documented at specific times. Primary outcome was severity of primary graft dysfunction within the first 72 hours. RESULTS: Primary graft dysfunction grade was progressively lower in patients treated after introduction of the guideline (P = .01). Lower postoperative fluid balances (P = .01) and vasopressor doses (P = .007) were seen, with no associated renal dysfunction. There were no differences in duration of mechanical ventilation or mortality. Nonadherence to the guideline occurred in 10 cases (18%). CONCLUSIONS: Implementation of an evidence-based guideline for managing respiratory and hemodynamic status is feasible and safe and was associated with reduction in severity of primary graft dysfunction. Further studies are required to determine whether such a guideline would lead to a consistent reduction in severity of primary graft dysfunction at other institutions. Creation of a protocol for postoperative care provides a template for further studies of novel therapies or management strategies for primary graft dysfunction.
Authors:
Judy Currey; David V Pilcher; Andrew Davies; Carlos Scheinkestel; Mari Botti; Michael Bailey; Greg Snell
Related Documents :
7230295 - Treatment of severe burns with widely meshed skin autograft and meshed skin allograft o...
18586765 - Graft intolerance syndrome in children with failed kidney allografts--clinical presenta...
17452895 - No association of factor v leiden, prothrombin g20210a, and mthfr c677t gene polymorphi...
20104485 - Early diagnosis of primary nonfunction and indication for reoperation after liver trans...
16382015 - Endothelial dysfunction contributes to renal function-associated cardiovascular mortali...
12484345 - Differential effect of diarrhea on fk506 versus cyclosporine a trough levels and result...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-11
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  139     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-28     Completed Date:  2010-03-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  154-61     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 The American Association for Thoracic Surgery. All rights reserved.
Affiliation:
Faculty of Health, Medicine, Nursing and Behavioural Sciences, Deakin University, 221 Burwood Hwy, Burwood 3125, Victoria, Australia. judy.currey@deakin.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Guidelines as Topic*
Humans
Lung Transplantation*
Male
Middle Aged
Postoperative Care
Primary Graft Dysfunction / physiopathology*
Severity of Illness Index
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high...
Next Document:  Outcomes of the bidirectional Glenn procedure in patients less than 3 months of age.